Vertex Pharmaceuticals
American biopharmaceutical company
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. Founded in 1989 by Joshua Boger and Kevin J. Kinsella, Vertex is known for its focus on developing small molecule drugs for the treatment of serious diseases.
History[edit | edit source]
Vertex Pharmaceuticals was established in 1989 in Cambridge, Massachusetts. The company was founded by Joshua Boger, a former Merck executive, and Kevin J. Kinsella, a venture capitalist. Vertex was one of the first biotechnology firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Research and Development[edit | edit source]
Vertex is renowned for its research and development in the field of cystic fibrosis (CF). The company has developed several breakthrough therapies for CF, including ivacaftor, lumacaftor, and tezacaftor. These drugs target the underlying causes of CF, providing significant improvements in lung function and quality of life for patients.
Products[edit | edit source]
Vertex's product portfolio includes several approved drugs, primarily focused on cystic fibrosis. The company's flagship product, ivacaftor, was the first drug to treat the underlying cause of CF in patients with specific mutations. Other notable products include lumacaftor/ivacaftor and tezacaftor/ivacaftor.
Pipeline[edit | edit source]
Vertex continues to invest heavily in its research pipeline, exploring treatments for other serious diseases such as sickle cell disease, beta thalassemia, and pain management. The company is also investigating the use of gene editing technologies, such as CRISPR, in collaboration with other biotech firms.
Corporate Structure[edit | edit source]
Vertex Pharmaceuticals is headquartered in Boston, Massachusetts, with additional research facilities in San Diego, California, and Oxford, England. The company is publicly traded on the NASDAQ under the ticker symbol VRTX.
Community Engagement[edit | edit source]
Vertex is committed to community engagement and corporate social responsibility. The company supports various initiatives aimed at improving science education and increasing access to healthcare.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
